ArticleBMC infectious diseases2019

Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.

Cristóbal Ramírez Sevilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.